In esophageal squamous cell carcinoma (ESCC), METTL3 and YTHDF collaborate to downregulate adenomatous polyposis coli (APC) expression, thereby activating the Wnt/β‐catenin signaling pathway and promoting aerobic glycolysis.392. Here, METTL3 is linked to esophageal squamous cell carcinoma.